quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:06:04·913d
NEWSRelease
AcelRx Pharmaceuticals Inc. logo
Ambrx Biopharma Inc. logo
Apollomics Inc. logo
+9

12 Health Care Stocks Moving In Monday's Pre-Market Session

ACRX· AcelRx Pharmaceuticals Inc.AMAM· Ambrx Biopharma Inc.APLM· Apollomics Inc.BIOC· Biocept Inc.CBIO· Crescent Biopharma Inc.INVO· INVO BioScience Inc.
Health Care
Original source

Companies

  • ACRX
    AcelRx Pharmaceuticals Inc.
    Health Care
  • AMAM
    Ambrx Biopharma Inc.
    Health Care
  • APLM
    Apollomics Inc.
    Health Care
  • BIOC
    Biocept Inc.
    Health Care
  • CBIO
    Crescent Biopharma Inc.
    Health Care
  • INVO
    INVO BioScience Inc.
    Health Care
  • LMDX
    LumiraDx Limited
    Health Care
  • MIRA
    MIRA Pharmaceuticals Inc.
    Health Care
  • OTLK
    Outlook Therapeutics Inc.
    Health Care
  • RVMD
    Revolution Medicines Inc.
    Health Care
  • SLGC
    SomaLogic Inc.
    Health Care
  • TCBP
    TC BioPharm (Holdings) plc
    Health Care

Recent analyst ratings

  • Mar 16RVMDUpdateJefferies-
  • Feb 27RVMDUpdateUBS$145.00
  • Jan 28CBIOUpdatePiper Sandler$35.00
  • Jan 21CBIOUpdateGuggenheim$35.00
  • Nov 18RVMDUpdateWolfe Research$75.00
  • Nov 3RVMDUpdateRBC Capital Mkts$77.00

Related

  • SEC9h
    Outlook Therapeutics Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
  • PR10h
    Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
  • SEC18h
    SEC Form 424B5 filed by Outlook Therapeutics Inc.
  • PR1d
    Outlook Therapeutics Announces $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
  • PR2d
    Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting
  • PR2d
    Revolution Medicines to Present Preclinical Data on Innovative Mutant-Targeted Catalytic RAS(ON) Inhibitor at the 2026 AACR Annual Meeting
  • SEC2d
    SEC Form DEFA14A filed by Crescent Biopharma Inc.
  • SEC2d
    SEC Form DEFA14A filed by Crescent Biopharma Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022